Comment on

• Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group.

  Ziegler EJ, Fisher CJ Jr, Sprung CL, Straube RC, Sadoff JC, Foulke GE, Wortel CH, Fink MP, Dellinger RP, Teng NN, et al. Ziegler EJ, et al. N Engl J Med. 1991 Feb 14;324(7):429-36. doi: 10.1056/NEJM199102143240701. N Engl J Med. 1991. PMID: 1988827 Clinical Trial.